Translation Regulation by Enterovirus Proteinase

肠道病毒蛋白酶的翻译调控

基本信息

  • 批准号:
    9793337
  • 负责人:
  • 金额:
    $ 48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-03-01 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

The long term goal of this research is to understand the mechanism by which enteroviruses such as poliovirus (PV) and Coxsackievirus (CVB3) control cellular and viral translation in infected cells and in turn, discern how translation and gene expression are regulated normally. Translation regulation mechanisms now encompass translation silencing (e.g. microRNAs) and dynamic assembly/disassembly of RNA granules, stress granules (SG) and P-bodies (PB) that contain translationally-silenced mRNPs. These structures assist cell homeostasis during stress and serve as temporary storage/triage sites for mRNPs, and in the case of PBs, sites for mRNA decay. We discovered that PV and CVB3 destroys-disperses both SGs and PBs, the former by cleavage of G3BP1, a key factor that nucleates formation of stress granules. Our emerging evidence suggests stress responses are linked to innate immune responses at several levels to form an integrated stress/innate immune response. In this funding period we discovered that SGs are stress-activated platforms to signal innate immunity and that G3BP1 mediates activation of PKR and NF-kB. We have also discovered that G3BP1 assembly of SGs is mediated by reversible arginine methylation on G3BP1 and have linked methylation to functional innate immunity output of SGs. In this proposal we will elucidate the role of protein arginine methylation in innate immune activation as we have now found recruitment of a key methyl- reader protein TDRD3 and several innate immune factors to SGs is dependent on methylation state of G3BP1. We have found the methyl-reader TDRD3 is antiviral, Aim 2 will elucidate the role of TDRD3 in recruitment and activation of innate immune factors in the absence of G3BP1 and the impact of its cleavage by virus protease. Aim 3 will determine molecular mechanisms of activation of both PKR that is non-methylation dependent and NF-kB by G3BP1. This proposal is innovative since the both the (i) role SGs as a signaling platforms in innate immunity and (ii) the role of protein methylation in innate immune activation are novel. The proposed work is significant since it is relevant to a broad range of DNA and RNA viruses that promote SG formation and it promises to uncover unprecedented insights into novel protein-mRNP interactions that link stress signaling to innate immune activation. This will open new conceptual avenues for antiviral development.
这项研究的长期目标是了解肠道病毒 如脊髓灰质炎病毒(PV)和柯萨奇病毒(CVB 3)控制细胞和病毒翻译, 感染的细胞,进而了解翻译和基因表达如何正常调节。 翻译调节机制现在包括翻译沉默(例如microRNA)和翻译抑制(例如,微RNA)。 RNA颗粒、应激颗粒(SG)和P体(PB)的动态组装/拆卸, 含有预防性沉默的mRNP。这些结构有助于细胞在压力下的自我平衡 并作为mRNP的临时储存/分类位点,在PB的情况下,作为mRNA的位点 腐烂我们发现PV和CVB 3破坏-分散SGs和PBs,前者通过 G3 BP 1的裂解,这是使应力颗粒形成成核的关键因素。我们新兴 有证据表明,压力反应与先天免疫反应在几个层面上有关, 形成一个整合的压力/先天免疫反应。在这个融资期内,我们发现, SGs是应激激活的平台,用于发出先天免疫信号,并且G3 BP 1介导 PKR和NF-κ B的激活。我们还发现,G3 BP 1组装的SGs是 通过G3 BP 1上的可逆精氨酸甲基化介导,并将甲基化与功能性 SG的先天免疫输出。在这个建议中,我们将阐明蛋白质精氨酸的作用, 甲基化在先天免疫激活中的作用,因为我们现在已经发现了一个关键的甲基- 阅读器蛋白TDRD 3和几种先天免疫因子对SGs依赖于甲基化 G3 BP 1的状态。我们已经发现甲基阅读器TDRD 3是抗病毒的,目的2将阐明甲基阅读器TDRD 3的抗病毒性。 TDRD 3在缺乏G3 BP 1的先天免疫因子的募集和激活中的作用 以及病毒蛋白酶对其切割的影响。目标3将确定 非甲基化依赖的PKR和NF-κ B都被G3 BP 1激活。这项建议 是创新的,因为(i)SG作为先天免疫中的信号平台的作用和(ii) 蛋白质甲基化在先天免疫激活中作用是新的。拟议的工作是 因为它与促进SG的广泛的DNA和RNA病毒相关, 形成,并有望揭示前所未有的见解,新的蛋白质mRNP 将压力信号与先天免疫激活联系起来的相互作用。这将开启新的概念 开发抗病毒药物的途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard E Lloyd其他文献

Richard E Lloyd的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard E Lloyd', 18)}}的其他基金

Oral vaccine interactions in human intestinal enteroids
口服疫苗在人肠道中的相互作用
  • 批准号:
    9759760
  • 财政年份:
    2018
  • 资助金额:
    $ 48万
  • 项目类别:
POLY(A)-BINDING PROTEIN-RNA COMPLEX
多聚 (A) 结合蛋白-RNA 复合物
  • 批准号:
    8361110
  • 财政年份:
    2011
  • 资助金额:
    $ 48万
  • 项目类别:
POLY(A)-BINDING PROTEIN-RNA COMPLEX
多聚 (A) 结合蛋白-RNA 复合物
  • 批准号:
    8168604
  • 财政年份:
    2010
  • 资助金额:
    $ 48万
  • 项目类别:
POLY(A)-BINDING PROTEIN-RNA COMPLEX
多聚 (A) 结合蛋白-RNA 复合物
  • 批准号:
    7953816
  • 财政年份:
    2008
  • 资助金额:
    $ 48万
  • 项目类别:
Translation Regulation by Enterovirus Proteinase
肠道病毒蛋白酶的翻译调控
  • 批准号:
    6479624
  • 财政年份:
    2002
  • 资助金额:
    $ 48万
  • 项目类别:
Translation Regulation by Enterovirus Proteinase
肠道病毒蛋白酶的翻译调控
  • 批准号:
    10216998
  • 财政年份:
    2002
  • 资助金额:
    $ 48万
  • 项目类别:
Translation Regulation by Enterovirus Proteinase
肠道病毒蛋白酶的翻译调控
  • 批准号:
    7993090
  • 财政年份:
    2002
  • 资助金额:
    $ 48万
  • 项目类别:
Translation Regulation by Enterovirus Proteinase
肠道病毒蛋白酶的翻译调控
  • 批准号:
    10447044
  • 财政年份:
    2002
  • 资助金额:
    $ 48万
  • 项目类别:
Translation Regulation by Enterovirus Proteinase
肠道病毒蛋白酶的翻译调控
  • 批准号:
    6625857
  • 财政年份:
    2002
  • 资助金额:
    $ 48万
  • 项目类别:
Translation Regulation by Enterovirus Proteinase
肠道病毒蛋白酶的翻译调控
  • 批准号:
    7538415
  • 财政年份:
    2002
  • 资助金额:
    $ 48万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 48万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 48万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 48万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 48万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 48万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 48万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 48万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了